ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,601 | 62.26398 | 0 |
male
| 0 | 8 | 450 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 26,205 | null | null | 29 |
black
| 37.195313 | 65 | 0.567993 | 0.372986 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 8 | 74 | 2.099609 | 132 | 36 | 38.79688 | 419 | null | 5.699219 | 0.699951 | 135 | 7.379883 | 77 | 14 | 1,750 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,602 | 76.82996 | 0 |
male
| 0 | 25 | 449 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 17 |
$25-$50k
| 9 | 120,051 | null | null | 24.5 |
white
| 21 | 34 | 0.642944 | 0.541992 | 33 | 0 | 0 |
yes
| 0.75 | 0.5 |
no dnr
| 25 | 130 | 15.099609 | 115 | 40 | 35 | 185.6875 | 2.899902 | 0.699951 | 1.099854 | 139 | 7.5 | 116 | 14 | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,603 | 45.27899 | 1 |
male
| 1 | 7 | 7 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5 | 12 |
under $11k
| 9 | 21,231 | null | null | 20.5 |
black
| 32.398438 | 55 | 0.600952 | 0.411987 | 2 | 0 | 0 |
no
| 0.4 | 0.88 |
dnr after sadm
| 6 | 72 | 9.898438 | 83 | 20 | 36.39844 | 319 | null | null | 0.799927 | 135 | 7.479492 | 102 | 18 | 500 | null | 6 |
<2 mo. follow-up
| 6 |
5,604 | 54.793 | 0 |
female
| 0 | 8 | 449 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 10 |
$25-$50k
| 0 | 11,367 | null | null | 9 |
white
| 20.398438 | 35 | 0.899902 | 0.831909 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 8 | 71 | 6.899414 | 100 | 18 | 36.5 | 361.875 | null | 0.699951 | 0.799927 | 138 | 7.439453 | 86 | 8 | 2,400 | null | null |
SIP>=30
| 3.366699 |
5,605 | 58.61697 | 1 |
male
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 0 |
under $11k
| 0 | 39,128 | null | null | 22 |
white
| 24 | 34 | 0.779907 | 0.707886 | 9 | 0 | 0 |
no
| 0.8 | 0.3 |
dnr after sadm
| 4 | 53 | 6.799805 | 108 | 20 | 38 | null | null | 8.199219 | 0.699951 | 130 | null | 80 | 9 | 1,185 | null | 0 |
<2 mo. follow-up
| 0 |
5,606 | 46.26398 | 1 |
male
| 1 | 15 | 15 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 80,718 | null | null | 36.666657 |
other
| 38.796875 | 63 | 0.208984 | 0.113998 | 3 | 0 | 0 |
metastatic
| 0.6 | 0.6 |
dnr after sadm
| 11 | 73 | 7.799805 | 76 | 24 | 36.89844 | 242.84375 | 3 | 0.599976 | 0.699951 | 139 | 7.369141 | 227 | 14 | null | null | 0 |
<2 mo. follow-up
| 0 |
5,607 | 72.88696 | 1 |
male
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 0 | 122,871 | null | null | 50 |
white
| 51.695313 | 78 | 0.042 | 0.011999 | 11 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 10 | 138 | 14 | 105 | 29 | 38.69531 | 380 | 2.099609 | 0.199982 | 1.899902 | 155 | 7.469727 | 621 | 43 | 3,135 | null | null |
<2 mo. follow-up
| 1.925293 |
5,608 | 57.659 | 1 |
female
| 1 | 31 | 31 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 191,281 | null | null | 48.25 |
white
| 20.199219 | 26 | 0.842896 | 0.78894 | 6 | 1 | 0 |
no
| 0.96 | 0.94 |
dnr after sadm
| 12 | 65 | 6.899414 | 115 | 30 | 35 | 231.65625 | 3.399902 | null | 0.799927 | 131 | 7.439453 | 142 | 30 | 2,375 | null | 0 |
<2 mo. follow-up
| 0 |
5,609 | 66.72095 | 1 |
female
| 1 | 38 | 38 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 4 |
$11-$25k
| 44 | null | null | null | 35.25 |
black
| 25.5 | 73 | 0.554932 | 0.441956 | 6 | 0 | 0 |
no
| 0.05 | 0.01 | null | null | 81 | 6.199219 | 72 | 20 | 37.79688 | null | 2.699707 | 3.399902 | 1.199951 | 130 | null | 104 | 15 | null | null | 0 |
<2 mo. follow-up
| 0 |
5,610 | 77.65094 | 0 |
male
| 0 | 25 | 447 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 | null | 0 | 90,077 | null | null | 28 |
white
| 29.898438 | 70 | 0.643921 | 0.543945 | 1 | 0 | 0 |
no
| 0.3 | 0.2 |
dnr after sadm
| 2 | 63 | 11.699219 | 110 | 44 | 37.69531 | 114.28125 | 3.799805 | 0.899902 | 0.699951 | 138 | 7.469727 | 129 | 32 | 2,125 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,611 | 70.15997 | 0 |
male
| 0 | 23 | 446 |
Coma
|
Coma
| 0 | null |
under $11k
| 0 | 62,877 | null | null | 29.333328 |
black
| 16.597656 | 31 | 0.787964 | 0.746948 | 1 | 0 | 0 |
no
| 0.5 | 0.45 |
no dnr
| 23 | 52 | 20.796875 | 135 | 22 | 37.69531 | 110.90625 | null | 6.399414 | 2.799805 | 132 | 7.379883 | 50 | 96 | 126 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,612 | 37.51099 | 0 |
male
| 0 | 18 | 446 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 37 | 71,649 | null | null | 33.666657 |
white
| 26.097656 | 45 | 0.747925 | 0.668945 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 18 | 105 | 8.798828 | 160 | 14 | 36.5 | 271.375 | 2.899902 | 0.5 | 0.599976 | 138 | 7.519531 | 171 | 14 | 930 | null | null | null | 2.772949 |
5,613 | 44.60199 | 1 |
male
| 0 | 6 | 15 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4 | 10 |
under $11k
| 0 | 17,393 | null | null | 14 |
white
| 20.296875 | 35 | 0.859985 | 0.767944 | 1 | 0 | 0 |
no
| 0.75 | 0.65 |
no dnr
| 6 | 123 | 11.398438 | 125 | 20 | 36.89844 | 144.4375 | 2.399902 | 1.699951 | 2.399902 | 146 | 7.469727 | 240 | 28 | 3,670 | 6 | 5 |
<2 mo. follow-up
| 5 |
5,614 | 61.73297 | 0 |
female
| 0 | 11 | 446 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 9 | null | 9 | 39,205 | null | null | 34.5 |
other
| 37.898438 | 48 | 0.510986 | 0.309998 | 1 | 1 | 0 |
no
| 0.35 | 0.3 |
dnr after sadm
| 1 | 68 | 5.699219 | 74 | 28 | 36.29688 | null | null | null | 1.899902 | 138 | null | 79 | 41 | 1,000 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,615 | 39.67697 | 0 |
male
| 0 | 11 | 446 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
$25-$50k
| 44 | 35,968 | null | null | 29 |
black
| 26.699219 | 41 | 0.735962 | 0.652954 | 1 | 0 | 0 |
no
| 0.85 | 0.84 |
no dnr
| 11 | 79 | 5.5 | 80 | 20 | 36.59375 | null | 3.699707 | null | 0.799927 | 145 | null | 98 | 11 | 975 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,616 | 75.30499 | 1 |
female
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 8 |
under $11k
| 0 | 139,100 | null | null | 37 |
black
| 30.398438 | 63 | 0.45697 | 0.337952 | 17 | 0 | 0 |
yes
| 0.6 | 0.5 |
dnr after sadm
| 8 | 73 | 10.199219 | 76 | 24 | 38.69531 | null | 3.599609 | 0.299988 | 0.599976 | 134 | null | 85 | 8 | 3,100 | null | 5 |
<2 mo. follow-up
| 5 |
5,617 | 54.20898 | 0 |
male
| 0 | 9 | 445 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 16 |
$11-$25k
| 0 | 7,800 | null | null | 13 |
white
| 25.597656 | 41 | 0.830933 | 0.723999 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 9 | 84 | 10.099609 | 76 | 22 | 35.29688 | 404.75 | 3.199707 | 1 | 1.5 | 134 | 7.489258 | 107 | 88 | 950 | 0 | 5 |
no(M2 and SIP pres)
| 5 |
5,618 | 41.87799 | 1 |
male
| 0 | 4 | 389 |
Lung Cancer
|
Cancer
| 1 | 14 |
$25-$50k
| 0 | 10,471 | null | null | 12 |
white
| 12 | 12 | 0.831909 | 0.633911 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 4 | 108 | 5.799805 | 125 | 6 | 36.39844 | 197.5 | 2.399902 | 7.299805 | 1.099854 | 145 | 7.359375 | 103 | 14 | 2,070 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,619 | 44.10098 | 1 |
male
| 0 | 5 | 196 |
Lung Cancer
|
Cancer
| 1 | 12 |
under $11k
| 9 | 14,569 | null | null | 15 |
white
| 7.699219 | 12 | 0.859985 | 0.68689 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 28 | 41.09375 | 0 | 0 | 36.59375 | 88.5625 | null | null | 1.599854 | 149 | 7.379883 | 163 | 53 | 110 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,620 | 56.50897 | 1 |
male
| 1 | 14 | 14 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 |
$11-$25k
| 0 | 34,959 | null | null | 19.333328 |
other
| 24.5 | 26 | 0.836914 | 0.73291 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 6 | 105 | 17.199219 | 125 | 24 | 39.5 | 266.625 | null | 0.599976 | 0.699951 | 131 | 7.489258 | 87 | 6 | 1,375 | null | 3 |
<2 mo. follow-up
| 3 |
5,621 | 81.85596 | 0 |
male
| 0 | 8 | 444 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 10 |
under $11k
| 0 | 5,708 | null | null | 8 |
white
| 20.199219 | 34 | 0.802979 | 0.681885 | 1 | 0 | 0 |
no
| 0.8 | 0.65 |
no dnr
| 8 | 165 | 10.199219 | 105 | 12 | 38.09375 | 147.5 | 2.299805 | 0.599976 | 0.899902 | 145 | 7.359375 | 160 | 21 | 4,500 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,622 | 59.67999 | 1 |
male
| 0 | 18 | 146 |
Colon Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 23,874 | null | null | 9.666664 |
white
| 9 | 9 | 0.904907 | 0.780884 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 18 | 62 | 9.699219 | 75 | 32 | 36.19531 | 179.5625 | 3.199707 | 4 | 2 | 139 | 7.419922 | 137 | 47 | 88.1875 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,623 | 51.504 | 1 |
female
| 1 | 20 | 20 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
$25-$50k
| 9 | 96,981 | null | null | 25 |
black
| 22.5 | 33 | 0.797974 | 0.731934 | 13 | 1 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 17 | 78 | 22.5 | 70 | 32 | 35.09375 | 190 | 2.899902 | 0.399963 | 0.799927 | 138 | 7.359375 | 208 | 12 | 1,920 | null | 0 |
<2 mo. follow-up
| 0 |
5,624 | 19.81899 | 0 |
male
| 0 | 18 | 442 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 13 |
$25-$50k
| 0 | 37,577 | null | null | 23.666656 |
white
| 21.597656 | 35 | 0.928955 | 0.902954 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 18 | 125 | 9.898438 | 125 | 11 | 39.19531 | 330 | null | null | 0.5 | 135 | 7.40918 | 184 | 7 | 1,865 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,625 | 38.35699 | 0 |
male
| 0 | 14 | 442 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 | null | 0 | 28,330 | null | null | 14.333328 |
black
| 29.699219 | 46 | 0.802979 | 0.737915 | 2 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 14 | 108 | 24.296875 | 75 | 12 | 38 | 230 | 1.799805 | null | 7.5 | 130 | 7.439453 | 330 | 73 | 90 | 0 | 0 | null | 0 |
5,626 | 81.24799 | 1 |
male
| 0 | 16 | 91 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 5 |
$11-$25k
| 0 | 35,584 | null | null | 20 |
white
| 26.796875 | 51 | 0.586914 | 0.47699 | 3 | 0 | 0 |
yes
| 0.25 | 0.05 |
dnr after sadm
| 12 | 73 | 8.298828 | 100 | 22 | 36.5 | null | null | null | 2 | 133 | null | 88 | 34 | null | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
5,627 | 81.45898 | 1 |
male
| 0 | 19 | 349 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 7 |
under $11k
| 0 | 148,940 | null | null | 24.666656 |
white
| 23.898438 | 23 | 0.656982 | 0.557983 | 27 | 0 | 0 |
no
| 0.25 | 0.15 |
dnr after sadm
| 2 | 68 | 12.699219 | 82 | 20 | 36.29688 | null | 3.599609 | 0.599976 | 0.699951 | 151 | null | 89 | 12 | 1,000 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,628 | 49.52197 | 1 |
male
| 0 | 6 | 53 |
Lung Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 10,604 | null | null | 20 |
white
| 28 | 22 | 0.484985 | 0.165985 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
dnr after sadm
| 4 | 112 | 9.199219 | 105 | 41 | 37.79688 | 161.21875 | null | null | 0.899902 | 140 | 7.449219 | 135 | 13 | 2,850 | 0 | 0 |
<2 mo. follow-up
| 0 |
5,629 | 19.127 | 0 |
female
| 0 | 4 | 439 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 17,649 | null | null | 18 |
white
| 23 | 19 | 0.921997 | 0.893921 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 4 | 104 | 8.699219 | 112 | 20 | 37.5 | null | 3.099609 | 0.599976 | 0.899902 | 135 | null | 314 | 11 | 5,700 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,630 | 79.41998 | 1 |
male
| 1 | 52 | 52 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 13 | null | 9 | 134,458 | null | null | 31.75 |
white
| 19 | 38 | 0.806885 | 0.74292 | 1 | 0 | 0 |
no
| 0.7 | 0.65 |
dnr after sadm
| 48 | 107 | 11.599609 | 50 | 22 | 36.69531 | 155 | null | null | 0.899902 | 135 | 7.469727 | 103 | 23 | 2,625 | null | 6 |
<2 mo. follow-up
| 6 |
5,631 | 36.06799 | 1 |
male
| 0 | 32 | 142 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 7 |
under $11k
| 0 | 73,203 | null | null | 19 |
black
| 20.398438 | 35 | 0.889893 | 0.850952 | 7 | 1 | 0 |
no
| null | null |
no dnr
| 32 | 52 | 36.898438 | 145 | 10 | 39.09375 | 167.5 | null | null | 1.5 | 139 | 7.399414 | 145 | 17 | 1,650 | 2 | 1 |
SIP>=30
| 1 |
5,632 | 69.66699 | 1 |
female
| 0 | 15 | 326 |
Colon Cancer
|
Cancer
| 1 | 11 |
$25-$50k
| 0 | 25,405 | null | null | 14.333328 |
white
| 13.798828 | 19 | 0.8479 | 0.664917 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.75 |
no dnr
| 15 | 78 | 10.199219 | 65 | 16 | 36.19531 | 642.75 | null | 1.699951 | 1.099854 | 140 | 7.349609 | 158 | 10 | 2,950 | null | 1 | null | 1 |
5,633 | 34.42297 | 0 |
male
| 0 | 4 | 439 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 10 |
under $11k
| 9 | 3,491 | null | null | 8 |
black
| 26.5 | 35 | 0.810913 | 0.69397 | 1 | 0 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 4 | 58 | 21.699219 | 115 | 10 | 38.59375 | 150 | null | null | 2.199707 | 139 | 7.489258 | 156 | 54 | 1,315 | null | null |
no(M2 and SIP pres)
| 2.38916 |
5,634 | 46.58698 | 1 |
female
| 0 | 45 | 365 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 |
>$50k
| 37 | 125,548 | null | null | 32.75 |
black
| 23.796875 | 40 | 0.75 | 0.671997 | 3 | 1 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 45 | 113 | null | 55 | 30 | 36.5 | null | null | null | null | 140 | null | 420 | null | 4,005 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,635 | 50.57098 | 1 |
female
| 1 | 7 | 7 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 0 | 42,242 | null | null | 18 |
black
| 21 | 25 | 0.825928 | 0.715942 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 7 | 155 | 6.799805 | 105 | 30 | 36.39844 | 144.4375 | null | null | 1.299805 | 137 | 7.509766 | 267 | 26 | 1,460 | 4 | 4 |
<2 mo. follow-up
| 4 |
5,636 | 74.85797 | 1 |
female
| 0 | 41 | 52 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 44 | 51,726 | null | null | 20 |
white
| 23.796875 | 40 | 0.620972 | 0.515991 | 1 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 7 | 58 | 19.699219 | 115 | 56 | 38.59375 | 200 | 3.099609 | 36.195313 | 4.199219 | 137 | 7.40918 | 122 | 136 | 665 | null | 0 |
<2 mo. follow-up
| 0 |
5,637 | 68.71698 | 1 |
male
| 1 | 21 | 21 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 7 | null | 0 | 84,442 | null | null | 29.333328 |
white
| 28.097656 | 35 | 0.599976 | 0.492981 | 1 | 0 | 0 |
yes
| 0.1 | 0.05 |
dnr after sadm
| 14 | 79 | 10.099609 | 68 | 20 | 37.69531 | null | 4 | 0.599976 | 0.899902 | 138 | null | 86 | 7 | 4,970 | null | 1 |
<2 mo. follow-up
| 1 |
5,638 | 66.54596 | 1 |
male
| 0 | 40 | 165 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 162,193 | null | null | 34.75 |
white
| 21.398438 | 26 | 0.796997 | 0.72998 | 7 | 0 | 0 |
no
| null | null |
no dnr
| 40 | 115 | 13.699219 | 135 | 32 | 38.59375 | 185.6875 | null | null | 0.599976 | 136 | 7.479492 | 185 | 9 | 950 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,639 | 63.75098 | 0 |
female
| 0 | 33 | 437 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 | null | 0 | 106,855 | null | null | 28.75 |
white
| 23.398438 | 44 | 0.647949 | 0.547974 | 11 | 0 | 0 |
metastatic
| 0.7 | 0.5 |
no dnr
| 33 | 72 | 33.5 | 65 | 32 | 37.69531 | 116.3125 | 3 | 2.099609 | 0.899902 | 131 | 7.399414 | 98 | 15 | 3,475 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
5,640 | 57.487 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 13 | null | 0 | 78,351 | null | null | 32 |
white
| 37.398438 | 57 | 0.533936 | 0.418945 | 3 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 103 | 5.699219 | 64 | 28 | 36.5 | 340 | null | 0.5 | 0.699951 | 137 | 7.40918 | 133 | 14 | 550 | null | 0 |
<2 mo. follow-up
| 0 |
5,641 | 72.73596 | 0 |
female
| 0 | 40 | 436 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 |
under $11k
| 26 | 145,725 | null | null | 31.25 |
black
| 26.5 | 65 | 0.602905 | 0.495972 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 40 | 60 | 15.5 | 105 | 24 | 38.89844 | 170 | 2.599609 | 0.5 | 4.899414 | 141 | 7.389648 | 232 | 61 | 3,765 | null | 2 |
no(M2 and SIP pres)
| 2 |
5,642 | 57.29199 | 0 |
male
| 0 | 31 | 435 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
>$50k
| 0 | 121,247 | null | null | 22.5 |
white
| 26.699219 | 41 | 0.750977 | 0.671997 | 6 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 31 | 122 | 0.099991 | 115 | 42 | 38.79688 | 135 | null | 1.699951 | 0.5 | 136 | 7.439453 | 232 | 12 | 5,620 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,643 | 70.73499 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 100 | 20,379 | null | null | 34 |
white
| 41 | 71 | 0.018997 | 0.004 | 1 | 0 | 0 |
no
| 0.1 | 0.05 |
dnr after sadm
| 3 | 75 | 5.299805 | 72 | 24 | 36.39844 | null | 2.5 | 5.799805 | 1 | 134 | null | 112 | 31 | 925 | null | null |
<2 mo. follow-up
| 3.334473 |
5,644 | 64.43799 | 0 |
male
| 0 | 52 | 434 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 165,091 | null | null | 13.75 |
white
| 12.199219 | 20 | 0.924927 | 0.871948 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 52 | 107 | 10.798828 | 45 | 34 | 35.19531 | 115.29688 | null | null | 0.5 | 133 | 7.339844 | 131 | 20 | 1,730 | null | null | null | 2.231934 |
5,645 | 72.85699 | 1 |
male
| 0 | 14 | 225 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 10 |
under $11k
| 9 | 35,895 | null | null | 22 |
black
| 21.699219 | 37 | 0.740967 | 0.659912 | 1 | 1 | 0 |
yes
| 0.7 | 0.5 |
no dnr
| 14 | 81 | 8.599609 | 68 | 20 | 37.79688 | null | null | 0.599976 | 0.699951 | 138 | null | 116 | 4 | null | 1 | null | null | 1.166748 |
5,646 | 77.35797 | 0 |
female
| 0 | 10 | 433 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 9 | 87,387 | null | null | 27.5 |
white
| 18.597656 | 19 | 0.75293 | 0.674927 | 21 | 1 | 0 |
no
| null | null |
no dnr
| 10 | 122 | null | 140 | 12 | 36 | 205 | null | null | 1.199951 | 141 | 7.519531 | 103 | 32 | 165.5 | null | null | null | 2.695313 |
5,647 | 69.76599 | 1 |
female
| 0 | 3 | 101 |
Colon Cancer
|
Cancer
| 2 | 12 |
under $11k
| 0 | 11,018 | null | null | 9 |
white
| 17.199219 | 23 | 0.804932 | 0.583984 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 3 | 42 | 30.097656 | 155 | 8 | 35.89844 | 256.625 | 1.199951 | 2.5 | 4 | 133 | 7.279297 | 109 | 136 | 712 | null | null |
SIP>=30
| 1.869629 |
5,648 | 69.40497 | 1 |
male
| 0 | 13 | 388 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | 12 |
under $11k
| 0 | 28,535 | null | null | 23 |
white
| 26.597656 | 24 | 0.748901 | 0.603882 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 13 | 75 | 11.398438 | 155 | 34 | 38.29688 | 240 | 1.199951 | null | 1.799805 | 142 | 7.459961 | 229 | 48 | 3,990 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,649 | 49.45697 | 1 |
male
| 0 | 15 | 83 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 44 | null | null | null | 24 |
white
| 18.699219 | 41 | 0.762939 | 0.687988 | 17 | 0 | 0 |
no
| 0.6 | 0.5 | null | null | 72 | 19 | 45 | 34 | 38.09375 | 233.3125 | 2.799805 | 0.699951 | 0.699951 | 136 | 7.449219 | 94 | 39 | 1,375 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,650 | 51.82199 | 0 |
male
| 0 | 16 | 432 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 |
under $11k
| 0 | 75,528 | null | null | 17 |
white
| 29.296875 | 36 | 0.738892 | 0.657959 | 4 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 16 | 132 | 12.199219 | 125 | 32 | 36.19531 | 215 | 2.699707 | 4.399414 | 2.799805 | 145 | 7.479492 | 79 | 100 | 2,325 | null | 0 |
SIP>=30
| 0 |
5,651 | 82.65594 | 1 |
female
| 0 | 8 | 53 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 7 | null | 26 | 17,117 | null | null | 15.5 |
white
| 28.296875 | 30 | 0.533936 | 0.334961 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr before sadm
| -1 | 73 | 7.799805 | 105 | 22 | 35.79688 | 200 | null | null | 1.099854 | 141 | 7.369141 | 96 | 20 | 2,300 | 0 | 0 |
<2 mo. follow-up
| 0 |
5,652 | 50.06198 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 50,018 | null | null | 48 |
white
| 41.195313 | 106 | 0.522949 | 0.407959 | 1 | 0 | 0 |
no
| 0.3 | 0.15 |
dnr after sadm
| 3 | 72 | 6.199219 | 119 | 32 | 35.5 | 293.3125 | null | null | 1.099854 | 138 | 7.389648 | 69 | 29 | 2,525 | null | 0 |
<2 mo. follow-up
| 0 |
5,653 | 61.26199 | 0 |
male
| 0 | 18 | 431 |
Colon Cancer
|
Cancer
| 2 | 8 |
$25-$50k
| 0 | 37,422 | null | null | 18.666656 |
white
| 35.09375 | 27 | 0.429993 | 0.122986 | 1 | 1 | 0 |
metastatic
| null | null |
no dnr
| 18 | 48 | 13.699219 | 135 | 47 | 39.09375 | 148 | null | 0.599976 | 1.699951 | 147 | 7.389648 | 211 | 21 | 1,945 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,654 | 50.20898 | 0 |
male
| 0 | 10 | 430 |
Colon Cancer
|
Cancer
| 1 | 14 |
$25-$50k
| 0 | 14,872 | null | null | 11.5 |
white
| 15.099609 | 6 | 0.863892 | 0.694946 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 10 | 38 | 18.097656 | 115 | 27 | 39 | 100 | 2 | 4.099609 | 2.5 | 148 | 7.349609 | 162 | 71 | 2,040 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
5,655 | 45.76599 | 1 |
male
| 0 | 4 | 38 |
Lung Cancer
|
Cancer
| 2 | 12 | null | 0 | 5,333 | null | null | 13 |
white
| 43.195313 | 54 | 0.088989 | 0.003 | 1 | 1 | 0 |
metastatic
| 0.4 | 0.1 |
dnr after sadm
| 2 | 72 | 10.398438 | 75 | 8 | 39 | 120 | 2 | 0.699951 | 1.099854 | 140 | 7.399414 | 68 | 17 | 1,770 | 3 | 4 |
<2 mo. follow-up
| 4 |
5,656 | 70.34595 | 0 |
male
| 0 | 14 | 428 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 9 | 22,967 | null | null | 14.333328 |
white
| 24.5 | 45 | 0.754883 | 0.677979 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 14 | 68 | 15.298828 | 115 | 30 | 38.39844 | 226.65625 | 1.799805 | 1.099854 | 6.799805 | 141 | 7.349609 | 77 | 71 | 5 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,657 | 60.47897 | 0 |
female
| 0 | 9 | 428 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 8 |
under $11k
| 0 | 11,988 | null | null | 13 |
white
| 22.398438 | 34 | 0.859985 | 0.768921 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 9 | 55 | 5.799805 | 70 | 36 | 35.79688 | 203.3125 | 1.5 | 0.5 | 2.5 | 133 | 7.359375 | 139 | 50 | 2,760 | 2 | 0 |
SIP>=30
| 0 |
5,658 | 75.29395 | 1 |
male
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
>$50k
| 44 | 23,497 | null | null | 37 |
white
| 31.699219 | 43 | 0.133972 | 0.060997 | 4 | 0 | 0 |
metastatic
| 0.1 | 0 |
dnr after sadm
| 2 | 152 | 5.5 | 60 | 30 | 38.69531 | 228.5625 | null | null | 0.899902 | 134 | 7.439453 | 103 | 13 | 1,320 | null | 0 |
<2 mo. follow-up
| 0 |
5,659 | 65.396 | 1 |
male
| 0 | 25 | 38 |
COPD
|
COPD/CHF/Cirrhosis
| 5 | null | null | 9 | 78,471 | null | null | 26.25 |
white
| 31 | 34 | 0.662964 | 0.487976 | 1 | 1 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 16 | 108 | 9.699219 | 160 | 35 | 37.79688 | 165 | null | null | 0.699951 | 137 | 7.479492 | 130 | 17 | 3,775 | null | null |
<2 mo. follow-up
| 3.592773 |
5,660 | 69.08698 | 1 |
male
| 0 | 8 | 225 |
Lung Cancer
|
Cancer
| 1 | 14 | null | 0 | 13,090 | null | null | 13 |
white
| 16.097656 | 6 | 0.715942 | 0.436951 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.3 |
no dnr
| 8 | 61 | 5 | 76 | 24 | 36.79688 | null | 2.5 | 1.699951 | 3 | 136 | null | 120 | 56 | 1,275 | 0 | null | null | 0.494751 |
5,661 | 59.61398 | 1 |
female
| 0 | 8 | 173 |
Colon Cancer
|
Cancer
| 1 | 15 |
>$50k
| 0 | 17,474 | null | null | 10 |
white
| 3 | 16 | 0.940918 | 0.859985 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.8 |
no dnr
| 8 | 67 | 15.398438 | 105 | 28 | 35.89844 | 170 | 3.299805 | null | 4.599609 | 127 | 7.349609 | 200 | 101 | 3,355 | 0 | null | null | 0.494751 |
5,662 | 51.06897 | 0 |
male
| 0 | 50 | 424 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 0 | 153,904 | null | null | 33.25 |
hispanic
| 30 | 19 | 0.766968 | 0.692993 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 50 | 112 | 15.5 | 115 | 50 | 39.09375 | 191.40625 | null | 0.899902 | 0.799927 | 141 | 7.449219 | 103 | 11 | 4,955 | null | null |
no(M2 and SIP pres)
| 2.137207 |
5,663 | 55.36798 | 1 |
male
| 0 | 12 | 226 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | 1 |
under $11k
| 0 | 41,291 | null | null | 37 |
white
| 22.199219 | 29 | 0.783936 | 0.653931 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 12 | 138 | 10 | 135 | 25 | 37.79688 | 167.5 | null | null | 6 | 136 | 7.399414 | 101 | 58 | 0 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,664 | 68.646 | 0 |
female
| 0 | 8 | 423 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 0 | 14,600 | null | null | 6 |
white
| 19.796875 | 25 | 0.837891 | 0.782959 | 2 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 8 | 67 | 9.298828 | 70 | 20 | 36.5 | null | 2.099609 | 1.399902 | 1.299805 | 132 | null | 59 | 40 | 4,450 | 1 | null |
no(M2 and SIP pres)
| 1.166748 |
5,665 | 72.71198 | 0 |
male
| 0 | 7 | 424 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
>$50k
| 0 | 10,007 | null | null | 9.5 |
white
| 23 | 36 | 0.797974 | 0.674927 | 1 | 0 | 0 |
no
| 0.95 | 0.75 |
no dnr
| 7 | 73 | 5.699219 | 96 | 20 | 36.29688 | null | 3.899902 | 0.5 | 0.799927 | 137 | null | 90 | 5 | 5,175 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,666 | 67.50397 | 0 |
male
| 0 | 49 | 422 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 37 | 162,444 | null | null | 26 |
white
| 27.296875 | 61 | 0.5 | 0.381958 | 16 | 0 | 0 |
no
| 0.5 | 0.45 |
no dnr
| 49 | 79 | 5.799805 | 64 | 16 | 37 | null | 3.599609 | 0.799927 | 0.899902 | 137 | null | 90 | 11 | 4,725 | null | 0 |
SIP>=30
| 0 |
5,667 | 74.81696 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 | null | 44 | 22,608 | null | null | 31 |
white
| 22.699219 | 32 | 0.644897 | 0.543945 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 73 | 12.099609 | 119 | 22 | 35.79688 | 476 | null | null | 0.799927 | 132 | 7.479492 | 208 | 11 | 3,520 | null | null |
<2 mo. follow-up
| 2.480957 |
5,668 | 74.93195 | 1 |
male
| 1 | 42 | 42 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 |
$11-$25k
| 9 | null | null | null | 24 |
white
| 43.09375 | 46 | 0.247986 | 0.144989 | 1 | 0 | 0 |
no
| 0.4 | 0.2 | null | null | 77 | 5.799805 | 66 | 24 | 36.39844 | null | null | 2 | 1.699951 | 132 | null | 88 | 34 | 1,200 | null | 7 |
<2 mo. follow-up
| 7 |
5,669 | 40.24899 | 0 |
female
| 0 | 49 | 422 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 26 | 211,918 | null | null | 42.5 |
white
| 34.796875 | 69 | 0.629883 | 0.527954 | 1 | 0 | 0 |
no
| 0.4 | 0.3 |
no dnr
| 49 | 113 | 3.199707 | 72 | 22 | 37.69531 | null | 3.899902 | 1.299805 | 1.199951 | 136 | null | 112 | 13 | 3,600 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,670 | 70.89697 | 1 |
male
| 1 | 20 | 20 |
Lung Cancer
|
Cancer
| 4 | 13 | null | 0 | 28,242 | null | null | 14.666664 |
white
| 30.597656 | 30 | 0.330994 | 0.064987 | 1 | 1 | 0 |
metastatic
| 0.4 | 0.4 |
dnr after sadm
| 12 | 108 | 14.5 | 104 | 32 | 35.79688 | 242.84375 | null | 1.299805 | 1 | 139 | 7.479492 | 112 | 37 | 3,900 | null | 0 |
<2 mo. follow-up
| 0 |
5,671 | 34.60098 | 0 |
female
| 0 | 56 | 421 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 227,914 | null | null | 41 |
black
| 27.699219 | 38 | 0.851929 | 0.800903 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 56 | 62 | 8.298828 | 125 | 44 | 36.69531 | 280 | 2.599609 | 1.5 | 1.299805 | 138 | 7.419922 | 108 | 28 | 2,315 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,672 | 81.71899 | 1 |
female
| 1 | 7 | 7 |
Coma
|
Coma
| 2 | null |
under $11k
| 44 | 26,992 | null | null | 30 |
black
| 23.5 | 30 | 0.250977 | 0.18399 | 1 | 1 | 0 |
yes
| 0.5 | 0.5 |
dnr after sadm
| 4 | 113 | 43.398438 | 125 | 29 | 38 | 187.5 | 2.5 | 1.399902 | 6.699219 | 139 | 7.329102 | 112 | 87 | 2,055 | null | 3 |
<2 mo. follow-up
| 3 |
5,673 | 66.43695 | 1 |
male
| 0 | 6 | 180 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 12,589 | null | null | 15 |
white
| 14.099609 | 10 | 0.758911 | 0.504883 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.5 |
no dnr
| 6 | 65 | 16.597656 | 105 | 36 | 38.89844 | 306.625 | 2 | null | 1.899902 | 160 | 7.459961 | 129 | 35 | 1,365 | null | null | null | 2.085938 |
5,674 | 55.754 | 0 |
male
| 0 | 24 | 420 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 |
>$50k
| 37 | 75,213 | null | null | 28.333328 |
white
| 33.59375 | 95 | 0.468994 | 0.349976 | 3 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 24 | 57 | 6.099609 | 110 | 9 | 37.59375 | 175.5 | null | null | 0.899902 | 135 | 7.449219 | 142 | 16 | 2,645 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,675 | 65.55194 | 1 |
male
| 0 | 32 | 63 |
Coma
|
Coma
| 1 | 12 | null | 94 | 65,156 | null | null | 25 |
white
| 21.699219 | 25 | 0.294983 | 0.224976 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 4 | 78 | 8.898438 | 118 | 34 | 36.89844 | null | 2.799805 | 0.799927 | 0.799927 | 139 | null | 91 | 4 | 2,700 | null | 0 | null | 0 |
5,676 | 68.84094 | 1 |
female
| 0 | 12 | 32 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | null | null | 0 | 13,711 | null | null | 6.5 |
white
| 25.199219 | 26 | 0.775879 | 0.642944 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 72 | 5.5 | 115 | 14 | 37.09375 | 210 | 3.299805 | 0.699951 | 0.599976 | 136 | 7.379883 | 96 | 3 | 3,905 | null | null |
<2 mo. follow-up
| 3.021484 |
5,677 | 86.17395 | 1 |
male
| 1 | 4 | 4 |
Coma
|
Coma
| 0 | null | null | 100 | 7,012 | null | null | 8 |
white
| 19.296875 | 31 | 0.139984 | 0.089996 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 118 | 20.5 | 53 | 36 | 38.19531 | 236.65625 | 2.099609 | 0.399963 | 1 | 134 | 7.449219 | 92 | 31 | 1,540 | null | null |
<2 mo. follow-up
| 2.823731 |
5,678 | 50.61697 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 26 | 82,086 | null | null | 40 |
black
| 42.898438 | 80 | 0.212982 | 0.117996 | 22 | 0 | 0 |
no
| null | null |
dnr after sadm
| 4 | 115 | 17.199219 | 115 | 7 | 37.79688 | 213.3125 | 2 | 0.299988 | 1 | 133 | 7.439453 | 243 | 22 | 3,590 | null | null |
<2 mo. follow-up
| 2.580078 |
5,679 | 48.73099 | 0 |
female
| 0 | 11 | 418 |
Lung Cancer
|
Cancer
| 1 | 12 | null | 0 | 15,076 | null | null | 10.5 |
white
| 5.399414 | 12 | 0.890991 | 0.751953 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.5 |
no dnr
| 11 | 79 | 4.099609 | 75 | 20 | 36.69531 | null | null | 0.599976 | 0.799927 | 139 | null | 212 | 8 | 1,100 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,680 | 60.92499 | 0 |
female
| 0 | 44 | 418 |
Coma
|
Coma
| 0 | 12 |
under $11k
| 61 | 115,272 | null | null | 31.5 |
black
| 18.597656 | 28 | 0.553955 | 0.484985 | 3 | 0 | 0 |
no
| 0.05 | 0.05 |
no dnr
| 44 | 65 | 9.599609 | 72 | 12 | 36.19531 | null | 2.699707 | 17.597656 | 0.699951 | 136 | null | 95 | 11 | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,681 | 80.51495 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 |
under $11k
| 9 | 57,044 | null | null | 41 |
white
| 23.796875 | 45 | 0.657959 | 0.559937 | 8 | 1 | 0 |
no
| 0.3 | 0.2 |
dnr after sadm
| 2 | 125 | 6.899414 | 170 | 8 | 40.29688 | 438.0625 | null | null | 0.599976 | 134 | 7.479492 | 377 | 8 | 2,820 | null | 0 |
<2 mo. follow-up
| 0 |
5,682 | 49.54398 | 0 |
female
| 0 | 6 | 417 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 | null | 9 | 19,758 | null | null | 23 |
black
| 21 | 14 | 0.85791 | 0.80896 | 2 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 6 | 75 | 8.298828 | 68 | 20 | 37 | null | 2 | 4.899414 | 0.899902 | 129 | null | 112 | 12 | null | 0 | 0 |
SIP>=30
| 0 |
5,683 | 68.44098 | 1 |
male
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 17 |
>$50k
| 44 | 22,156 | null | null | 46 |
white
| 28 | 40 | 0.322998 | 0.208984 | 4 | 0 | 0 |
yes
| 0.05 | 0.05 |
dnr after sadm
| 2 | 73 | 18.898438 | 78 | 12 | 36.59375 | 276.625 | null | 1 | 6.799805 | 131 | 7.459961 | 139 | 107 | 1,005 | null | 7 |
<2 mo. follow-up
| 7 |
5,684 | 65.47797 | 1 |
male
| 1 | 4 | 4 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 4,656 | null | null | 9 |
white
| 29.398438 | 32 | 0.668945 | 0.495972 | 1 | 0 | 0 |
yes
| 0.6 | 0.4 |
no dnr
| 4 | 70 | 8.798828 | 110 | 16 | 36.39844 | 217.5 | 2.899902 | null | 4.5 | 130 | 7.419922 | 74 | 113 | 2,510 | 6 | 4 |
<2 mo. follow-up
| 4 |
5,685 | 73.04297 | 1 |
female
| 0 | 12 | 263 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 6 |
under $11k
| 0 | 29,016 | null | null | 25.5 |
black
| 24.398438 | 59 | 0.772949 | 0.699951 | 1 | 1 | 0 |
no
| 0.2 | 0.2 |
no dnr
| 12 | 142 | 5.799805 | 115 | 28 | 38.59375 | 227.5 | 2.699707 | null | 0.699951 | 138 | 7.429688 | 121 | 18 | 2,360 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,686 | 77.08698 | 1 |
male
| 0 | 19 | 65 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 39,533 | null | null | 26.333328 |
white
| 25.5 | 32 | 0.737915 | 0.588989 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 19 | 60 | 10.699219 | 115 | 5 | 36.79688 | 251.40625 | 1 | null | 1.099854 | 136 | 7.369141 | 141 | 7 | 3,352 | null | null | null | 2.953613 |
5,687 | 45.64499 | 0 |
male
| 0 | 7 | 415 |
Lung Cancer
|
Cancer
| 1 | 23 |
$25-$50k
| 0 | 7,302 | null | null | 6.5 |
white
| 21.097656 | 10 | 0.669922 | 0.370972 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.3 |
no dnr
| 7 | 48 | 22.398438 | 175 | 28 | 39.89844 | 130 | null | null | 0.899902 | 142 | 7.359375 | 178 | 18 | 1,710 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,688 | 50.02597 | 0 |
male
| 0 | 20 | 415 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 41 | 66,125 | null | null | 22 |
white
| 33.796875 | 70 | 0.185974 | 0.096985 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 20 | 108 | 15 | 70 | 4 | 36.09375 | 320 | null | null | 7.5 | 137 | 7.399414 | 121 | 47 | 0 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,689 | 78.72095 | 1 |
male
| 1 | 31 | 31 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
$11-$25k
| 41 | 112,577 | null | null | 32.75 |
black
| 34 | 56 | 0.237 | 0.135986 | 1 | 0 | 0 |
yes
| 0.2 | 0.1 |
dnr after sadm
| 4 | 105 | 13.298828 | 120 | 13 | 39.29688 | 193.3125 | 2.399902 | 1.799805 | 0.799927 | 133 | 7.449219 | 105 | 20 | 3,700 | null | 0 |
<2 mo. follow-up
| 0 |
5,690 | 55.38898 | 1 |
male
| 1 | 79 | 79 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 |
$11-$25k
| 0 | 292,373 | null | null | 41.75 |
white
| 31.5 | 57 | 0.669922 | 0.573975 | 5 | 0 | 0 |
no
| null | null |
dnr after sadm
| 17 | 49 | 5.5 | 0 | 0 | 39.29688 | 177 | 2.899902 | 0.5 | 1.199951 | 147 | 7.549805 | 312 | 28 | 4,065 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,691 | 63.24399 | 1 |
female
| 0 | 11 | 66 |
Coma
|
Coma
| 2 | 10 | null | 0 | 13,705 | null | null | 13 |
white
| 23.199219 | 27 | 0.651978 | 0.592896 | 1 | 0 | 0 |
yes
| 0.2 | 0.05 |
dnr before sadm
| -1 | 77 | 15.099609 | 84 | 20 | 36.09375 | null | 4.299805 | 0.699951 | 1.299805 | 142 | null | 92 | 26 | 1,125 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
5,692 | 95.53699 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 61 | 11,729 | null | null | 26 |
white
| 35.796875 | 66 | 0.088989 | 0.034996 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 4 | 107 | 71.6875 | 45 | 13 | 36.59375 | 251.84375 | 3.399902 | 0.599976 | 1.199951 | 138 | 7.40918 | 79 | 23 | 2,470 | null | 0 |
<2 mo. follow-up
| 0 |
5,693 | 27.25299 | 0 |
female
| 0 | 38 | 412 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 37 | 161,518 | null | null | 37 |
white
| 31.898438 | 47 | 0.652954 | 0.553955 | 7 | 0 | 0 |
no
| 0.6 | 0.2 |
no dnr
| 38 | 115 | 14 | 105 | 24 | 37.79688 | 340 | 2.699707 | null | 0.799927 | 136 | 7.469727 | 189 | 25 | 1,935 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,694 | 53.728 | 1 |
male
| 1 | 7 | 7 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 11 |
under $11k
| 37 | 33,447 | null | null | 36 |
black
| 27.699219 | 62 | 0.30896 | 0.196991 | 4 | 0 | 0 |
metastatic
| 0.3 | 0.15 |
dnr after sadm
| 2 | 103 | 8.699219 | 55 | 12 | 36.59375 | null | null | 0.299988 | 0.899902 | 141 | null | 128 | 14 | 850 | null | 1 |
<2 mo. follow-up
| 1 |
5,695 | 50.73199 | 1 |
male
| 0 | 4 | 185 |
Lung Cancer
|
Cancer
| 1 | 14 |
$25-$50k
| 0 | 5,207 | null | null | 11 |
white
| 18.296875 | 20 | 0.715942 | 0.436951 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.6 |
no dnr
| 4 | 115 | 8.199219 | 115 | 12 | 36.79688 | 142.5 | 3.299805 | null | 1.099854 | 135 | 7.359375 | 111 | 18 | 2,080 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,696 | 44.89798 | 0 |
male
| 0 | 12 | 411 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | 33,648 | null | null | 24 |
black
| 49.796875 | 36 | 0.097992 | 0.003 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 12 | 108 | 17.5 | 60 | 32 | 36.29688 | 286.625 | 1.899902 | 0.599976 | 1 | 140 | 7.459961 | 120 | 21 | 1,180 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,697 | 39.90997 | 0 |
male
| 0 | 6 | 411 |
Colon Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 8,356 | null | null | 12 |
black
| 6.099609 | 10 | 0.938965 | 0.85498 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 6 | 127 | 5.899414 | 120 | 10 | 38.5 | 157.5 | 1.899902 | 1.5 | 0.699951 | 127 | 7.459961 | 99 | 10 | 5,565 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,698 | 66.80896 | 1 |
male
| 1 | 11 | 11 |
Lung Cancer
|
Cancer
| 2 | 12 |
under $11k
| 9 | 9,857 | null | null | 11.5 |
white
| 24.398438 | 47 | 0.483948 | 0.164978 | 1 | 1 | 0 |
metastatic
| 0.2 | 0.05 |
dnr after sadm
| 3 | 72 | 6.799805 | 75 | 32 | 35.29688 | 287.75 | 2.699707 | 0.399963 | 1.299805 | 126 | 7.419922 | 96 | 49 | 2,555 | null | 0 |
<2 mo. follow-up
| 0 |
5,699 | 40.129 | 1 |
male
| 1 | 14 | 14 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 98,253 | null | null | 45 |
black
| 41.5 | 71 | 0.552979 | 0.439941 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 14 | 42 | 22 | 155 | 37 | 34.69531 | 234.28125 | 1.399902 | 1.699951 | 1.399902 | 144 | 7.199219 | 57 | 27 | 1,260 | null | 0 |
<2 mo. follow-up
| 0 |
5,700 | 40.24899 | 0 |
male
| 0 | 6 | 410 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 11,127 | null | null | 14 |
white
| 11 | 6 | 0.909912 | 0.791992 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.8 |
no dnr
| 6 | 130 | 6.399414 | 75 | 8 | 35 | 428.5625 | 2.099609 | 0.799927 | 0.699951 | 134 | 7.469727 | 244 | 7 | null | 0 | null | null | 0.494751 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.